Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Groskopf

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Neoplasia (New York, N.Y.)|April 5, 2013
Genome-wide association study identifies genetic determinants of urine PCA3 levels in menZhuo Chen, Jielin Sun, Seong-Tae Kim, et al.
Molecular Cancer|July 6, 2010
Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral bloodMatthias Jost, John R Day, Ryan Slaughter, et al.
BJU International|February 9, 2012
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkersNeesha C Dhani, Urban Emmenegger, Laurie Adams, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 7, 2007
A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracyLori J Sokoll, William Ellis, Paul Lange, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 13, 2014
A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohortMaria A Svensson, Sven Perner, Anna-Lena Ohlson, et al.
Urology|March 27, 2007
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsyLeonard S Marks, Yves Fradet, Ina Lim Deras, et al.
The Journal of Urology|February 26, 2008
PCA3: a molecular urine assay for predicting prostate biopsy outcomeIna L Deras, Sheila M J Aubin, Amy Blase, et al.
The Prostate|August 2, 2017
Epigenetic risk score improves prostate cancer risk assessmentLeander Van Neste, Jack Groskopf, William E Grizzle, et al.
European Urology|May 20, 2015
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk AssessmentScott A Tomlins, John R Day, Robert J Lonigro, et al.
The Journal of Urology|September 20, 2008
PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volumeEric J Whitman, Jack Groskopf, Amina Ali, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Neoplasia (New York, N.Y.)|April 5, 2013
Genome-wide association study identifies genetic determinants of urine PCA3 levels in menZhuo Chen, Jielin Sun, Seong-Tae Kim, et al.
Molecular Cancer|July 6, 2010
Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral bloodMatthias Jost, John R Day, Ryan Slaughter, et al.
BJU International|February 9, 2012
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkersNeesha C Dhani, Urban Emmenegger, Laurie Adams, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 7, 2007
A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracyLori J Sokoll, William Ellis, Paul Lange, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 13, 2014
A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohortMaria A Svensson, Sven Perner, Anna-Lena Ohlson, et al.
Urology|March 27, 2007
PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsyLeonard S Marks, Yves Fradet, Ina Lim Deras, et al.
The Journal of Urology|February 26, 2008
PCA3: a molecular urine assay for predicting prostate biopsy outcomeIna L Deras, Sheila M J Aubin, Amy Blase, et al.
The Prostate|August 2, 2017
Epigenetic risk score improves prostate cancer risk assessmentLeander Van Neste, Jack Groskopf, William E Grizzle, et al.
European Urology|May 20, 2015
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk AssessmentScott A Tomlins, John R Day, Robert J Lonigro, et al.
The Journal of Urology|September 20, 2008
PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volumeEric J Whitman, Jack Groskopf, Amina Ali, et al.
Pageof 3